TAKE Solutions Limited (TAKE.BO)
INR 16.89
(-0.18%)
INR 16.89
(-0.18%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.05 Billion INR | -144.39% |
| 2022 | -209.79 Million INR | -39.69% |
| 2021 | 269 Million INR | 235.36% |
| 2020 | -2.86 Billion INR | -118.84% |
| 2019 | 1.95 Billion INR | -48.89% |
| 2018 | 3.94 Billion INR | 27.28% |
| 2017 | 3.12 Billion INR | 16.32% |
| 2016 | 2.75 Billion INR | 26.19% |
| 2015 | 2.06 Billion INR | 38.14% |
| 2014 | 1.51 Billion INR | 1.89% |
| 2013 | 1.47 Billion INR | -12.6% |
| 2012 | 1.68 Billion INR | 19.86% |
| 2011 | 1.4 Billion INR | 25.09% |
| 2010 | 1.09 Billion INR | 25.11% |
| 2009 | 895.84 Million INR | -5.27% |
| 2008 | 945.64 Million INR | 8.13% |
| 2007 | 874.58 Million INR | 70.19% |
| 2006 | 513.88 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | -9.14 Million INR | -177.64% |
| 2023 FY | - INR | -144.39% |
| 2023 Q4 | -152.18 Million INR | -1441.98% |
| 2023 Q3 | 11.34 Million INR | -41.7% |
| 2023 Q2 | 19.45 Million INR | 312.8% |
| 2022 Q1 | 22.02 Million INR | 107.61% |
| 2022 FY | - INR | -39.69% |
| 2022 Q4 | 11.77 Million INR | 182.08% |
| 2022 Q3 | -14.34 Million INR | 93.49% |
| 2022 Q2 | -220.4 Million INR | -1100.91% |
| 2021 Q3 | -88.51 Million INR | -133.77% |
| 2021 Q2 | 262.1 Million INR | -20.99% |
| 2021 FY | - INR | 235.36% |
| 2021 Q1 | 331.73 Million INR | -50.49% |
| 2021 Q4 | -289.36 Million INR | -226.92% |
| 2020 FY | - INR | -118.84% |
| 2020 Q3 | 149.35 Million INR | 119.52% |
| 2020 Q2 | -765.1 Million INR | -79.54% |
| 2020 Q4 | 670.05 Million INR | 348.64% |
| 2020 Q1 | -426.13 Million INR | 71.29% |
| 2019 Q4 | -1.48 Billion INR | -232.8% |
| 2019 Q1 | 1.1 Billion INR | 46.49% |
| 2019 Q2 | 1.12 Billion INR | 1.92% |
| 2019 Q3 | 1.11 Billion INR | -0.65% |
| 2019 FY | - INR | -48.89% |
| 2018 Q1 | 1.01 Billion INR | 8.93% |
| 2018 Q4 | 753.46 Million INR | -17.13% |
| 2018 FY | - INR | 27.28% |
| 2018 Q3 | 909.2 Million INR | -23.31% |
| 2018 Q2 | 1.18 Billion INR | 16.56% |
| 2017 Q1 | 672.66 Million INR | -3.27% |
| 2017 Q2 | 710.61 Million INR | 5.64% |
| 2017 FY | - INR | 16.32% |
| 2017 Q3 | 811.77 Million INR | 14.23% |
| 2017 Q4 | 933.8 Million INR | 15.03% |
| 2016 FY | - INR | 26.19% |
| 2016 Q3 | 715.46 Million INR | 4.94% |
| 2016 Q4 | 695.4 Million INR | -2.8% |
| 2016 Q2 | 681.77 Million INR | 3.57% |
| 2016 Q1 | 658.26 Million INR | 1.14% |
| 2015 Q4 | 650.83 Million INR | 27.46% |
| 2015 FY | - INR | 38.14% |
| 2015 Q3 | 510.6 Million INR | -0.39% |
| 2015 Q1 | 666.35 Million INR | 59.25% |
| 2015 Q2 | 512.6 Million INR | -23.07% |
| 2014 Q2 | 346.71 Million INR | 5.58% |
| 2014 FY | - INR | 1.89% |
| 2014 Q4 | 418.42 Million INR | 3.88% |
| 2014 Q3 | 402.78 Million INR | 16.17% |
| 2014 Q1 | 328.4 Million INR | -10.12% |
| 2013 Q2 | 396.18 Million INR | 7.64% |
| 2013 Q4 | 365.37 Million INR | -8.75% |
| 2013 Q1 | 368.07 Million INR | 21.34% |
| 2013 FY | - INR | -12.6% |
| 2013 Q3 | 400.4 Million INR | 1.07% |
| 2012 FY | - INR | 19.86% |
| 2012 Q4 | 303.35 Million INR | -23.64% |
| 2012 Q3 | 397.23 Million INR | -7.54% |
| 2012 Q2 | 429.63 Million INR | -11.2% |
| 2012 Q1 | 483.84 Million INR | 29.36% |
| 2011 Q3 | 421.54 Million INR | 9.59% |
| 2011 Q2 | 384.67 Million INR | 0.0% |
| 2011 FY | - INR | 25.09% |
| 2011 Q4 | 374.02 Million INR | -11.27% |
| 2010 FY | - INR | 25.11% |
| 2009 FY | - INR | -5.27% |
| 2008 FY | - INR | 8.13% |
| 2007 FY | - INR | 70.19% |
| 2006 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.12 Million INR | 10479.692% |
| Biocon Limited | 41.52 Billion INR | 102.531% |
| Blue Jet Healthcare Limited | 2.29 Billion INR | 145.842% |
| Concord Biotech Limited | 4.65 Billion INR | 122.555% |
| Dishman Carbogen Amcis Limited | 3.07 Billion INR | 134.209% |
| FERMENTA BIOTECH LIMITED | 262.68 Million INR | 500.043% |
| GENOMIC VALLEY BIOTECH LIMITED | 147.4 Thousand INR | 713007.559% |
| Lyka Labs Limited | 167.58 Million INR | 727.034% |
| Panacea Biotec Limited | -200.6 Million INR | -423.848% |
| SAMSRITA LABS LIMITED | -2.46 Million INR | -42609.261% |
| Servoteach Industries Limited | - INR | Infinity% |
| SMS Lifesciences India Limited | 349.41 Million INR | 400.747% |
| Supriya Lifescience Limited | 1.83 Billion INR | 157.243% |
| Syngene International Limited | 10.84 Billion INR | 109.688% |
| Titan Biotech Limited | 360.29 Million INR | 391.66% |
| Transgene Biotek Limited | -4.33 Million INR | -24118.484% |
| Vanta Bioscience Limited | 14.19 Million INR | 7504.975% |